title: Beneficial effect of statins in multiple sclerosis: is it dose-dependent?
authors.forename: Armando
authors.initials: A
authors.lastname: Sena
authors.forename: Rui
authors.initials: R
authors.lastname: Pedrosa
authors.forename: M Graça
authors.initials: MG
authors.lastname: Morais
mesh_terms: D000069059:Atorvastatin; D004305:Dose-Response Relationship, Drug; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D007155:Immunologic Factors / Q000008:administration & dosage*; D008148:Lovastatin / Q000008:administration & dosage; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011758:Pyrroles / Q000008:administration & dosage; D019821:Simvastatin / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007155:Immunologic Factors; D011758:Pyrroles; D008148:Lovastatin; D000069059:Atorvastatin; D019821:Simvastatin